Literature DB >> 11840141

Intracranial hemorrhage following bone marrow transplantation: an autopsy study of 58 patients.

L F Bleggi-Torres1, B Werner, E L Gasparetto, B C de Medeiros, R Pasquini, C R de Medeiros.   

Abstract

Autopsy files of 180 patients were reviewed, who died after BMT between July 1987 and June 1998 and 58 (32.2%) cases, who had experienced intracranial hemorrhage (ICH) were selected. Age, sex, underlying disease, preparatory regimens, immunoprophylaxis, chronic and acute GVHD, survival of the patients and localization and size of hemorrhages were evaluated. There were 33 males and 25 females, with a mean age of 23.4 years. The main underlying disorders for which BMT was performed included SAA (n = 21), CML (n = 13) and AML (n = 10). Forty patients were found to have intraparenchymal hemorrhage, 35 had subarachnoid hemorrhage and eight patients had subdural hemorrhage. In 16 cases the CNS hemorrhage was so extensive that it was considered to be the main cause of death. There was no significant statistical difference concerning sex (P = 0.217), age (P = 0.296), underlying disease (P= 0.352), preparatory regimens (P = 0.07), immunoprophylaxis (P = 0.914), chronic and acute graft-versus-host disease (P = 0.107 and P = 0.631, respectively) and survival (P = 0.701) when comparing patients with or without ICH. However, the number of cases in which the CNS was defined as the main cause of death was higher among patients with ICH than in patients without ICH (n = 16 vs 15) (P = 0.011). We conclude that ICH is common and has a significant mortality rate following BMT.

Entities:  

Mesh:

Year:  2002        PMID: 11840141     DOI: 10.1038/sj.bmt.1703315

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  7 in total

Review 1.  CT and MR imaging of central nervous system effects of therapy in patients treated for hematological malignancies.

Authors:  Ali Guermazi; Yves Miaux; François Lafitte; Jean Ralph Zahar; Eliane Gluckman
Journal:  Eur Radiol       Date:  2003-12       Impact factor: 5.315

2.  Cerebrovascular disease after allogeneic hematopoietic stem cell transplantation: incidence, risk, and clinical outcome.

Authors:  Ting-An Lin; Jyh-Pyng Gau; Yao-Chung Liu; Po-Shen Ko; Hao-Yuan Wang; Sheng-Hsuan Chien; Chia-Jen Liu; Liang-Tsai Hsiao; Tzeon-Jye Chiou; Jin-Hwang Liu
Journal:  Int J Hematol       Date:  2019-03-12       Impact factor: 2.490

3.  Predicting mortality from intracranial hemorrhage in patients who undergo allogeneic hematopoietic stem cell transplantation.

Authors:  Xiying Ren; Qiusha Huang; Qingyuan Qu; Xuan Cai; Haixia Fu; Xiaodong Mo; Yu Wang; Yawei Zheng; Erlie Jiang; Yishan Ye; Yi Luo; Shaozhen Chen; Ting Yang; Yuanyuan Zhang; Wei Han; Feifei Tang; Wenjian Mo; Shunqing Wang; Fei Li; Daihong Liu; Xiaoying Zhang; Yicheng Zhang; Shuqing Feng; Feng Gao; Hailong Yuan; Dao Wang; Dingming Wan; Huan Chen; Yao Chen; Jingzhi Wang; Yuhong Chen; Ying Wang; Kailin Xu; Tao Lang; Xiaomin Wang; Hongbin Meng; Limin Li; Zhiguo Wang; Yanling Fan; Yingjun Chang; Lanping Xu; Xiaojun Huang; Xiaohui Zhang
Journal:  Blood Adv       Date:  2021-12-14

4.  Pathological features of bone marrow transplantation-related toxicity in a mouse.

Authors:  Yong Hoon Kim; Chang Su Ha; Hyun Sook Lee; Sun Hwa Lim; Kyoung Sik Moon; Moon Koo Chung; Hwa Young Son
Journal:  J Vet Sci       Date:  2009-12       Impact factor: 1.672

Review 5.  Management of stroke in cancer.

Authors:  Lisa R Rogers
Journal:  Curr Oncol Rep       Date:  2008-01       Impact factor: 5.075

6.  Intracranial hemorrhage in adult patients with hematological malignancies.

Authors:  Chien-Yuan Chen; Chan-Hwei Tai; Aristine Cheng; Hung-Chang Wu; Woei Tsay; Jia-Hau Liu; Pey-Ying Chen; Shang-Yi Huang; Ming Yao; Jih-Luh Tang; Hwei-Fang Tien
Journal:  BMC Med       Date:  2012-08-29       Impact factor: 8.775

7.  Intracranial haemorrhage in thrombocytopenic haematology patients--a nested case-control study: the InCiTe study protocol.

Authors:  Lise J Estcourt; Simon J Stanworth; Dave Collett; Mike F Murphy
Journal:  BMJ Open       Date:  2014-02-07       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.